Clark Estates Inc Biogen Inc. Transaction History

Clark Estates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $1.81 Million - $2.33 Million	-8,100 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $2.98 Million - $4.77 Million	-11,500 Reduced 58.67%	8,100 $2.81 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $2.6 Million - $3.05 Million	10,700 Added 120.22%	19,600 $5.48 Million
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $1.19 Million - $1.58 Million	-4,600 Reduced 34.07%	8,900 $2.38 Million
Q2 2018 Aug 07, 2018	BUY	$257.52 - $306.91 $3.48 Million - $4.14 Million	13,500 New	13,500 $3.92 Million

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Clark Estates Inc, based on Form 13F filings with the SEC.

Stay updated on Clark Estates Inc with notifications on news.